As the second leading cause of death globally, cancer is a worldwide health crisis, particularly as life expectancies continue to increase. In its final stages, cancer spreads throughout the body in a ...
A leading oncologist proposes classifying metastatic cancer by molecular alterations rather than organ origin, arguing that the shift could accelerate drug access.
UCLA and Stanford Medicine researchers, in collaboration with scientists from the University of Utah and Columbia University, ...
A newly discovered gene switch may help turn chemotherapy-resistant pancreatic cancer into a treatable disease.
EMR-based nudge interventions can influence molecular genotyping ordering behavior to promote comprehensive molecular testing and delivery of guideline-concordant care in the 1L treatment setting in ...
Newly discovered drug leverages the power of Pattern Discovery Engine™ (PDE) and is an extension of 2025 study wherein Pattern developed novel ...
A Targeted Methylation–Based Multicancer Early Detection Blood Test Preferentially Detects High-Grade Prostate Cancer While Minimizing Overdiagnosis of Indolent Disease This retrospective analysis ...
Scientists have identified a crucial molecular switch that decides whether pancreatic cancer cells resist chemotherapy or respond to it. The key player, a gene called GATA6, keeps tumours in a more ...
Researchers have identified a molecular "switch" that determines whether pancreatic cancer responds to or resists treatment, a finding that could make treatment-resistant tumors sensitive to drugs.
Scientists at Georgetown University's Lombardi Comprehensive Cancer Center have uncovered a new dual function for a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results